epifoam: Pharmaceutical manufacturers, suppliers, and packagers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Mylan Speciality Lp	EPIFOAM	hydrocortisone acetate; pramoxine hydrochloride	AEROSOL, METERED;TOPICAL	086457	ANDA	Viatris Specialty LLC	0037-6824-10	1 CANISTER in 1 CARTON (0037-6824-10) / 10 g in 1 CANISTER	2014-08-25
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: August 5, 2025

Introduction

Epifoam, a pharmaceutical foam predominantly used for dermatological applications, is recognized for its soothing, anti-inflammatory, and protective properties. Its formulations typically contain active ingredients such as hydrocortisone or other corticosteroids, mixed with a foam delivery system that ensures localized, controlled application. Given its therapeutic efficacy, the demand for Epifoam has risen globally, prompting pharmaceutical companies to establish a robust supply chain network.

This article delineates the leading suppliers of Epifoam, encompassing raw material providers, formulation manufacturers, and finished product distributors. Understanding the landscape of Epifoam suppliers enables stakeholders to optimize procurement strategies, ensure regulatory compliance, and secure supply chain stability amid market fluctuations.

Manufacturers of Epifoam

Several global pharmaceutical companies manufacture Epifoam and proprietary foam formulations. These firms often hold patents or trade secrets that distinguish their products within the therapeutic and dermatological markets.

1. 3M Healthcare

Overview: 3M is a prominent player with a diversified portfolio in healthcare, including topical foam formulations. Their expertise in medical adhesives and foam technologies positions them as a significant supplier of dermatological foam products like Epifoam.

Supply Capabilities: They supply both finished formulations and raw foam substrates that can be customized into therapeutic foams. Their global manufacturing footprint supports consistent supply to North America, Europe, and Asian markets.

2. GlaxoSmithKline (GSK)

Overview: GSK has historically developed and marketed corticosteroid foams for dermatology. Their proprietary formulations often include hydrocortisone-based products, marketed under various brand names.

Supply Capabilities: GSK maintains manufacturing facilities in Europe and North America, ensuring high-quality production of corticosteroid foams suitable for both prescription and over-the-counter markets.

3. Perrigo Company

Overview: Perrigo specializes in OTC pharmaceutical product manufacturing, including topical foams. They also supply to private-label providers, expanding their reach in the dermatology segment.

Supply Capabilities: Perrigo’s flexible manufacturing processes allow the production of foam formulations compliant with multiple regulatory standards. Their global supply network supports extensive regional distribution.

4. Teva Pharmaceutical Industries

Overview: Teva offers a range of dermatological formulations, including corticosteroid foams similar to Epifoam. Their focus on generic medication manufacturing makes them a key player in the supply chain.

Supply Capabilities: With manufacturing plants across Israel, Europe, and the US, Teva ensures scalable production capabilities aligned with market demand.

Raw Material Suppliers

The stability and efficacy of Epifoam depend heavily on raw material quality, primarily the foam propellants, corticosteroids, stabilizers, and excipients.

1. Honeywell International Inc.

Product Offerings: Honeywell supplies medical-grade, eco-friendly foam propellants such as hydrofluorocarbon (HFC) and hydrofluoroalkane (HFA), critical for delivering the foam formulation effectively.

Relevance: Consistent, regulatory-compliant propellants from Honeywell ensure the safety, efficacy, and stability of foam-based pharmaceuticals like Epifoam.

2. BASF SE

Product Offerings: As a leading supplier of excipients, stabilizers, and corticosteroid raw materials, BASF provides high-quality active ingredients used in Epifoam formulations.

Relevance: High-grade corticosteroids such as hydrocortisone emulsions and stabilizers manufactured by BASF contribute to product performance and regulatory approval.

3. Evonik Industries

Product Offerings: Evonik supplies specialty excipients, surfactants, and foam stabilizers that facilitate the optimal function and shelf life of Epifoam.

Relevance: Their products ensure the consistency and safety profile of foam formulations, critical for pharmaceutical applications.

Distribution and Supply Chain Considerations

Distribution plays a pivotal role in ensuring timely availability of Epifoam. Major pharmaceutical distributors such as McKesson, Cardinal Health, and Alliance Healthcare develop regional networks that source formulations directly from manufacturers or raw material suppliers.

Key factors influencing supply chain stability:

Regulatory compliance: Suppliers must adhere to Good Manufacturing Practices (GMP) and regional regulations (e.g., FDA, EMA).
Manufacturing capacity: Consistent capacity scaling ensures supply despite surges in demand, especially during global health crises.
Quality assurance: Reliable suppliers adhere to strict quality control protocols, minimizing risks of contamination or formulation instability.
Strategic sourcing: Diversifying suppliers mitigates risks associated with geopolitical or logistical disruptions.

Emerging Suppliers and Market Trends

With increasing global demand, new entrants are entering the Epifoam supply landscape, especially from emerging markets such as India and China. Companies like Sun Pharmaceutical Industries and Dr. Reddy's Laboratories are expanding their dermatological product portfolios, including foam-based formulations.

Market trend considerations:

Localization: Regional manufacturing reduces logistics costs and regulatory hurdles.
Innovation: Suppliers investing in eco-friendly foam propellants and advanced delivery systems attract interest.
Regulatory landscape: Suppliers capable of navigating complex geopolitical trade dynamics have a competitive advantage.

Conclusion

The supply landscape for Epifoam is characterized by a blend of established global pharmaceutical giants, raw material providers, and regional manufacturers. Ensuring a resilient supply chain requires aligning sourcing strategies with regulatory mandates, quality standards, and market trends. Stakeholders should prioritize diversified sourcing, rigorous supplier qualification, and continuous market monitoring to mitigate risks and optimize procurement processes.

Key Takeaways

Diversify sourcing: Engage multiple suppliers for raw materials and formulations to avoid supply disruptions.
Regulatory compliance: Prioritize suppliers with proven GMP adherence and ability to navigate regional regulatory requirements.
Leverage regional manufacturing: Consider regional suppliers to reduce logistics costs and expedite supply chain responsiveness.
Invest in quality assurance: Rigorous testing and validation ensure consistent product efficacy and safety.
Monitor market trends: Stay alert to emerging suppliers and technological innovations, especially eco-friendly propellants and delivery systems.

FAQs

Who are the leading manufacturers of Epifoam?
Major manufacturers include 3M Healthcare, GSK, Perrigo, and Teva, known for their dermatological foam formulations.
What raw materials are essential for Epifoam production?
High-quality corticosteroids, eco-friendly foam propellants (HFCs or HFAs), stabilizers, surfactants, and excipients from suppliers like BASF and Honeywell are critical.
How can companies ensure the stability of their Epifoam supply chain?
By diversifying suppliers, adhering to regulatory standards, maintaining quality protocols, and building regional manufacturing partnerships.
Are emerging markets becoming significant suppliers of Epifoam?
Yes, countries like India and China are increasing their presence through companies such as Sun Pharma and Dr. Reddy’s, emphasizing local manufacturing capabilities.
What are future trends impacting Epifoam supply?
The shift toward eco-friendly propellants, innovative foam delivery systems, and regional manufacturing hubs shape the evolving supply landscape.

Sources

[1] Bloomberg Industry Reports. "Pharmaceutical Foam Formulations Market Analysis." 2022.
[2] U.S. Food and Drug Administration (FDA). "GMP Compliance for Topical Pharmaceuticals." 2023.
[3] European Medicines Agency (EMA). "Regulatory Requirements for Dermal Foam Products." 2022.
[4] MarketWatch. "Global Dermatological Foam Market Growth and Trends." 2022.
[5] Company Annual Reports: 3M, GSK, Perrigo, Teva.

Suppliers and packagers for epifoam

epifoam

Suppliers for the Pharmaceutical Drug: Epifoam